Published in Yale J Biol Med on February 17, 1998
Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol Mol Biol Rev (2007) 4.13
Skin microbiota: a source of disease or defence? Br J Dermatol (2008) 2.81
Prostate cancer and inflammation: the evidence. Histopathology (2012) 2.60
Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother (2012) 2.02
Population genetic analysis of Propionibacterium acnes identifies a subpopulation and epidemic clones associated with acne. PLoS One (2010) 1.86
Propionibacterium acnes types I and II represent phylogenetically distinct groups. J Clin Microbiol (2005) 1.75
Comparative genomics and transcriptomics of Propionibacterium acnes. PLoS One (2011) 1.52
Arthroplastic and osteosynthetic infections due to Propionibacterium acnes: a retrospective study of 52 cases, 1995-2002. Eur J Clin Microbiol Infect Dis (2005) 1.45
Late implant infections caused by Propionibacterium acnes in scoliosis surgery. Eur Spine J (2005) 1.43
Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen. Clin Microbiol Rev (2014) 1.38
Taxonomy, Physiology, and Natural Products of Actinobacteria. Microbiol Mol Biol Rev (2015) 1.36
Proteomic identification of secreted proteins of Propionibacterium acnes. BMC Microbiol (2010) 1.28
Reverse transcriptase-PCR analysis of bacterial rRNA for detection and characterization of bacterial species in arthritis synovial tissue. Infect Immun (2000) 1.15
A mouse model of chronic prostatic inflammation using a human prostate cancer-derived isolate of Propionibacterium acnes. Prostate (2013) 1.09
Genotypic and antimicrobial characterisation of Propionibacterium acnes isolates from surgically excised lumbar disc herniations. Biomed Res Int (2013) 1.08
Multilocus sequence typing (MLST) analysis of Propionibacterium acnes isolates from radical prostatectomy specimens. Prostate (2012) 1.02
Quantification of the antibody response to Propionibacterium acnes in a patient with prosthetic valve endocarditis: - a case report. BMC Infect Dis (2016) 0.98
Infections and inflammation in prostate cancer. Am J Clin Exp Urol (2013) 0.95
Propionibacterium acnes and Staphylococcus epidermidis isolated from refractory endodontic lesions are opportunistic pathogens. J Clin Microbiol (2010) 0.94
Autoinflammatory bone disorders: update on immunologic abnormalities and clues about possible triggers. Curr Opin Rheumatol (2013) 0.88
Surgical site infections following spine surgery: eliminating the controversies in the diagnosis. Front Med (Lausanne) (2014) 0.87
Physical stress and bacterial colonization. FEMS Microbiol Rev (2014) 0.86
Complete Genome Sequence of a Propionibacterium acnes Isolate from a Sarcoidosis Patient. Genome Announc (2013) 0.80
Propionibacterium acnes as a cause of prosthetic valve aortic root abscess. J Clin Microbiol (2006) 0.80
Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: a 20-day-double-blind comparison to its individual components. Clinics (Sao Paulo) (2013) 0.78
Propionibacterium acnes populations involved in deep pathological samples and their dynamics along the cardiac surgical pathway. Eur J Clin Microbiol Infect Dis (2014) 0.76
Prosthetic valve endocarditis caused by Propionibacterium species successfully treated with coadministered rifampin: report of two cases. BMJ Case Rep (2013) 0.76
Spondylodiscitis occurring after diagnostic lumbar puncture: a case report. Case Rep Infect Dis (2013) 0.76
Optimal Length of Cultivation Time for Isolation of Propionibacterium acnes in Suspected Bone and Joint Infections Is More than 7 Days. J Clin Microbiol (2016) 0.75
Delayed Propionibacterium acnes surgical site infections occur only in the presence of an implant. Sci Rep (2016) 0.75
Propionibacterium prosthetic joint infection: experience from a retrospective database analysis. Eur J Orthop Surg Traumatol (2016) 0.75
Propionibacterium acnes biofilm is present in intervertebral discs of patients undergoing microdiscectomy. PLoS One (2017) 0.75
Infections caused by Propionibacterium species. Rev Infect Dis (1992) 2.02
Focal infections of the central nervous system due to Propionibacterium acnes. J Infect (1989) 1.55
Septic arthritis caused by Propionibacterium acnes. JAMA (1982) 1.45
Propionibacterium acnes causing an aortic root abscess. Br Heart J (1992) 1.39
Propionibacterium acnes as a cause of aggressive aortic valve endocarditis and importance of tissue grinding: case report and review. J Clin Microbiol (1994) 1.38
Endocarditis due to Propionibacterium acnes. Am J Clin Pathol (1980) 1.27
Comparison of the E test and a reference agar dilution method for susceptibility testing of anaerobic bacteria. Eur J Clin Microbiol Infect Dis (1992) 1.27
Isolation of Propionibacterium acnes from central nervous system infections. Anaerobe (1995) 1.18
Infectious arthritis due to Propionibacterium acnes in a prosthetic joint. Clin Infect Dis (1994) 1.06
Propionibacterium acnes endophthalmitis. Br J Ophthalmol (1991) 1.04
Adherence of bacteria to intraocular lenses: a prospective study. Br J Ophthalmol (1995) 0.99
Propionibacterium acnes: a neglected head and neck pathogen. Otolaryngol Head Neck Surg (1987) 0.85
The myoD gene family: nodal point during specification of the muscle cell lineage. Science (1991) 9.53
THE INFLUENCE OF FEAR ON THE ELECTROCARDIOGRAM. Br Heart J (1940) 9.23
Clinical microbiology of coryneform bacteria. Clin Microbiol Rev (1997) 8.40
A trans-spliced leader sequence on actin mRNA in C. elegans. Cell (1987) 7.24
von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med (1998) 6.17
Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol (1997) 4.20
Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods. J Clin Microbiol (1998) 4.07
16S rRNA gene sequencing versus the API 20 NE system and the VITEK 2 ID-GNB card for identification of nonfermenting Gram-negative bacteria in the clinical laboratory. J Clin Microbiol (2006) 3.25
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem (1993) 3.23
O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J Biol Chem (1997) 3.16
Whipple endocarditis without overt gastrointestinal disease: report of four cases. Ann Intern Med (1999) 2.75
Association of cervical artery dissection with recent infection. Arch Neurol (1999) 2.63
The detection of Aeromonas hydrophila in stool specimens. Health Lab Sci (1970) 2.49
Leukopenia and thrombocytopenia in a patient with early Lyme borreliosis. Clin Infect Dis (1996) 2.49
Potentially pathogenic, nonfermentative, H2S-producing gram-negative rod (1 b). Appl Microbiol (1970) 2.48
An apamin-sensitive Ca2+-activated K+ current in hippocampal pyramidal neurons. Proc Natl Acad Sci U S A (1999) 2.34
THE ELECTROCARDIOGRAM IN PELLAGRA. Br Heart J (1940) 2.30
Evaluation of differential and selective media for isolation of Aeromonas and Plesiomonas spp. from human feces. J Clin Microbiol (1983) 2.16
The role of opportunistic bacteria in human disease. Annu Rev Microbiol (1977) 2.15
Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope cleaning machine. Report of an outbreak and review of the literature. Chest (1992) 2.14
Barrier-to-autointegration factor (BAF) bridges DNA in a discrete, higher-order nucleoprotein complex. Proc Natl Acad Sci U S A (2000) 2.12
Characteristics of CDC group 1 and group 1-like coryneform bacteria isolated from clinical specimens. J Clin Microbiol (1993) 2.11
Halophilic vibrios from extraintestinal lesions in man. Infection (1973) 2.09
Four homologous domains in the primary structure of GrsB are related to domains in a superfamily of adenylate-forming enzymes. Mol Microbiol (1992) 2.06
Antimicrobial susceptibility patterns of some recently established coryneform bacteria. Antimicrob Agents Chemother (1996) 2.04
Ribosomal DNA sequencing for identification of aerobic gram-positive rods in the clinical laboratory (an 18-month evaluation). J Clin Microbiol (2003) 2.02
Effect of therapeutic concentrations of nitric oxide on bacterial growth in vitro. Crit Care Med (1998) 2.01
Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection (2011) 2.00
Unexpected high frequency of de novo unbalanced translocations in patients with Wolf-Hirschhorn syndrome (WHS). J Med Genet (2000) 2.00
Comparison of conventional and molecular methods for identification of aerobic catalase-negative gram-positive cocci in the clinical laboratory. J Clin Microbiol (2004) 1.96
Cloning of the tyrocidine synthetase 1 gene from Bacillus brevis and its expression in Escherichia coli. Mol Gen Genet (1985) 1.96
Gramicidin S biosynthesis operon containing the structural genes grsA and grsB has an open reading frame encoding a protein homologous to fatty acid thioesterases. J Bacteriol (1989) 1.95
Dopamine and glutamate induce distinct striatal splice forms of Ania-6, an RNA polymerase II-associated cyclin. Neuron (2001) 1.93
Effect of the size of the deletion and clinical manifestation in Wolf-Hirschhorn syndrome: analysis of 13 patients with a de novo deletion. Eur J Hum Genet (2000) 1.85
Analysis of a Caenorhabditis elegans Twist homolog identifies conserved and divergent aspects of mesodermal patterning. Genes Dev (1998) 1.79
Biology and clinical significance of virulence plasmids in Salmonella serovars. Clin Infect Dis (1995) 1.76
Growth regulation of a Salmonella plasmid gene essential for virulence. J Bacteriol (1991) 1.74
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Sequence analysis of the complete Caenorhabditis elegans myosin heavy chain gene family. J Mol Biol (1989) 1.72
Evaluation of a small "conventional" identification system for fermentative gramnegative rods using a computerized data base. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 1.68
The pie-1 and mex-1 genes and maternal control of blastomere identity in early C. elegans embryos. Cell (1992) 1.66
Deoxyribonuclease-indole medium and its use in an identification system for non-lactose fermenting gram-negative rods. Ann Clin Lab Sci (1973) 1.65
Zyxin is not colocalized with vasodilator-stimulated phosphoprotein (VASP) at lamellipodial tips and exhibits different dynamics to vinculin, paxillin, and VASP in focal adhesions. Mol Biol Cell (2001) 1.64
Correlation between the presence of sequences homologous to the vir region of Salmonella dublin plasmid pSDL2 and the virulence of twenty-two Salmonella serotypes in mice. Infect Immun (1990) 1.64
Primary identification of Aureobacterium spp. isolated from clinical specimens as "Corynebacterium aquaticum". J Clin Microbiol (1994) 1.64
Assignment of human-derived CDC group 1 coryneform bacteria and CDC group 1-like coryneform bacteria to the genus Actinomyces as Actinomyces neuii subsp. neuii sp. nov., subsp. nov., and Actinomyces neuii subsp. anitratus subsp. nov. Int J Syst Bacteriol (1994) 1.62
Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period. J Clin Microbiol (1996) 1.58
CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int (2007) 1.58
Streptobacillus moniliformis endocarditis in an HIV-positive patient. Infection (2001) 1.54
Central regulatory role for the RpoS sigma factor in expression of Salmonella dublin plasmid virulence genes. J Bacteriol (1995) 1.51
Successful treatment of angiosarcoma of the scalp by intralesional cytokine therapy and surface irradiation. J Eur Acad Dermatol Venereol (2000) 1.51
Evidence for a molecular complex consisting of Fyb/SLAP, SLP-76, Nck, VASP and WASP that links the actin cytoskeleton to Fcgamma receptor signalling during phagocytosis. J Cell Sci (2001) 1.48
Antimicrobial resistance of the genera Proteus, Providencia and Serratia with special reference to multiple resistance patterns. Med Microbiol Immunol (1972) 1.46
Clinical microbiology of unusual Pseudomonas species. Prog Clin Pathol (1973) 1.45
The Caenorhabditis elegans MYOD homologue HLH-1 is essential for proper muscle function and complete morphogenesis. Development (1994) 1.44
Characterization of Brevibacterium spp. from clinical specimens. J Clin Microbiol (1993) 1.44
Differentiation in throat cultures of group C and G streptococci from Streptococcus milleri with identical antigens. Eur J Clin Microbiol (1984) 1.43
A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND). Int J Stroke (2012) 1.42
DNA rearrangements of the actin gene cluster in Caenorhabditis elegans accompany reversion of three muscle mutants. J Mol Biol (1984) 1.40
Rubella IgM detection in pregnancy. Lancet (1990) 1.39
Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Infection (2008) 1.39
An immunochemical analysis of bacterial mucopeptides. J Immunol (1966) 1.36
The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats. J Pharmacol Exp Ther (2004) 1.35
Growth-phase regulation of plasmid virulence genes in Salmonella. Trends Microbiol (1995) 1.34
Evaluation of a new differential test for enterococci in the clinical laboratory. J Med Microbiol (1970) 1.34
Nuclear hormone receptor CHR3 is a critical regulator of all four larval molts of the nematode Caenorhabditis elegans. Proc Natl Acad Sci U S A (2001) 1.34
Epidemiology and clinical significance of nontuberculous mycobacteria in patients negative for human immunodeficiency virus in Switzerland. Clin Infect Dis (1992) 1.32
Selenocysteine-containing thioredoxin reductase in C. elegans. Biochem Biophys Res Commun (1999) 1.32
Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland. Infect Control Hosp Epidemiol (1999) 1.32
Serology to Bartonella (Rochalimaea) henselae may replace traditional diagnostic criteria for cat-scratch disease. Eur J Pediatr (1995) 1.31
Enteric infections and diarrhea in human immunodeficiency virus-infected persons: prospective community-based cohort study. Swiss HIV Cohort Study. Arch Intern Med (1999) 1.28
The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans. Infection (1983) 1.28
An active serine is involved in covalent substrate amino acid binding at each reaction center of gramicidin S synthetase. J Biol Chem (1991) 1.27
Biological role of gramicidin S in spore functions. Studies on gramicidin-S-negative mutants of Bacillus brevis ATCC9999. Eur J Biochem (1979) 1.27
Body-wall muscle formation in Caenorhabditis elegans embryos that lack the MyoD homolog hlh-1. Science (1992) 1.26
Bacterial replication initiator DnaA. Rules for DnaA binding and roles of DnaA in origin unwinding and helicase loading. Biochimie (2001) 1.24
Final results of the randomized phase III CHARTWEL-trial (ARO 97-1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC). Radiother Oncol (2011) 1.24
Evaluation of the colorimetric VITEK 2 card for identification of gram-negative nonfermentative rods: comparison to 16S rRNA gene sequencing. J Clin Microbiol (2007) 1.23
Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort. AIDS Res Hum Retroviruses (1999) 1.22
CHR3: a Caenorhabditis elegans orphan nuclear hormone receptor required for proper epidermal development and molting. Development (1998) 1.20
International multicenter evaluation of latex agglutination tests for identification of Staphylococcus aureus. J Clin Microbiol (2001) 1.20
Molecular cloning of an ornithine-activating fragment of the gramicidin S synthetase 2 gene from Bacillus brevis and its expression in Escherichia coli. J Bacteriol (1985) 1.19
Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus. J Infect Dis (1998) 1.19
Regulating cellular actin assembly. Curr Opin Cell Biol (2001) 1.19
Cultural recovery and determination of antimicrobial susceptibility in Helicobacter pylori by using commercial transport and isolation media. Infection (2005) 1.19
Occurrence of nonfermentative gram-negative rods other than Pseudomonas aeruginosa in the respiratory tract of children with cystic fibrosis. Helv Paediatr Acta (1982) 1.18
Salmonella typhimurium bacteremia: association with the virulence plasmid. J Infect Dis (1992) 1.18
Evaluation of probe chemistries and platforms to improve the detection limit of real-time PCR. J Microbiol Methods (2005) 1.17
A note on name, viability and urease tests of Campylobacter pylori. Eur J Clin Microbiol (1987) 1.16
Natural antibiotic susceptibility of Listeria species: L. grayi, L. innocua, L. ivanovii, L. monocytogenes, L. seeligeri and L. welshimeri strains. Clin Microbiol Infect (2000) 1.16
Accuracy of the KOH and vancomycin tests in determining the Gram reaction of non-enterobacterial rods. J Clin Microbiol (1983) 1.16
Improved methods for detection of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2001) 1.15
Unique organization of the dnaA region from Prochlorococcus marinus CCMP1375, a marine cyanobacterium. Mol Gen Genet (1998) 1.14
A cluster of Mycobacterium gordonae isolates from bronchoscopy specimens. Am Rev Respir Dis (1979) 1.13
Caenorhabditis elegans twist plays an essential role in non-striated muscle development. Development (2000) 1.13
MyoD and the specification of muscle and non-muscle fates during postembryonic development of the C. elegans mesoderm. Development (1998) 1.12
Fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in swine and cattle at slaughter in Switzerland. J Food Prot (2011) 1.12